期刊论文详细信息
Hereditary Cancer in Clinical Practice
Plasma homocysteine levels and genetic polymorphisms in folate metablism are associated with breast cancer risk in chinese women
Xu Wang2  Tao Zhou2  Weijiang Xu2  Juan Ni2  Neng Cao2  Tianning Zou1  Xiayu Wu2 
[1] Third Affiliated hospital of Kunming Medical College, Kunming, Yunnan 650101, China;School of Life Sciences, The Engineering Research Center of Sustainable Development and Utilization of Biomass Energy, Ministry of Education, Yunnan Normal University, Kunming, Yunnan 650500, China
关键词: Risk;    Breast cancer;    Hcy;    CBS;    MTRR;    MS;    SHMT;    Folate;   
Others  :  805827
DOI  :  10.1186/1897-4287-12-2
 received in 2013-05-30, accepted in 2014-02-07,  发布年份 2014
PDF
【 摘 要 】

Background

Folate plays a pivotal role in DNA synthesis, repair, methylation and homocysteine (Hcy) metabolism. Therefore, alterations in the folate-mediated one-carbon metabolism may lead to abnormal methylation proliferation, increases of tumor/neoplasia and vein thrombosis/cardiovascular risk. The serine hydroxymethyhransferase (SHMT), methionine synthase (MS), methionine synthase reductase (MTRR) and cystathionine beta synthase (CBS) regulate key reactions in the folate and Hcy metabolism. Therefore, we investigated whether the genetic variants of the SHMT, MS, MTRR and CBS gene can affect plasma Hcy levels and are associated with breast cancer risk.

Methods

Genotyping was performed by PCR-RFLP method. Plasma Hcy levels were measured by the fluorescence polarization immunoassay on samples of 96 cases and 85 controls.

Results

(a) The SHMT 1420 T, MS 2756G, MTRR 66G allele frequency distribution showed significant difference between case and controls (p < 0.01 ~ 0.05). (b) The concentration of plasma Hcy levels of SHMT 1420TT was significantly lower than that of the wild type, while the plasma Hcy levels of MS 2756GG, CBS 699TT/1080TT significantly higher than that of the wild type both in case and controls. The plasma Hcy levels of MTRR 66GG was significantly higher than that of wild type in cases. The plasma Hcy levels of the same genotype in cases were significantly higher than those of controls except SHMT 1420CC, MS 2756AA, MTRR 66GG; (c) Multivariate Logistic regression analysis showed that SHMT C1420T (OR = 0.527, 95% CI = 0.55 ~ 1.24), MS A2756G (OR = 2.32, 95% CI = 0.29 ~ 0.82), MTRR A66G (OR = 1.84, 95% CI = 0.25 ~ 1.66) polymorphism is significantly associated with breast cancer risk. And elevated plasma Hcy levels were significantly linked to increased risk of breast cancer (adjusted OR = 4.45, 95% CI = 1.89-6.24 for the highest tertile as compared with the lowest tertile).

Conclusions

The current study results seem to suggest a possibility that SHMT C1420T mutation may be negatively correlated with breast cancer susceptibility; while MS A2756G and MTRR A66G mutation may be positively associated with breast cancer risk. SHMT C1420T, MS A2756G, MTRR A66G, CBS C1080T, CBS C699T locus mutation may be factors affecting plasma levels of Hcy. The plasma Hcy levels could be metabolic risk factor for breast cancer risk to a certain extent.

【 授权许可】

   
2014 Wu et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140708083451848.pdf 2095KB PDF download
Figure 6. 57KB Image download
Figure 5. 57KB Image download
Figure 4. 53KB Image download
Figure 3. 58KB Image download
Figure 2. 51KB Image download
Figure 1. 46KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】
  • [1]Shetty MK: Screening for breast cancer with mammography: current status and an overview. Indian J Surg Oncol 2010, 1:218-223.
  • [2]Zhivetskii AV: Incidence of breast cancer in a goiter region of Northern Bukovina. Vrach Delo 1968, 7:37-41.
  • [3]Zakharova NA, Duffy SW, Mackay J, Kotliarov EV: Evaluation of the screening program for early diagnosis of breast cancer in the Khanty-Mansy Autonomous Region-Yugra. Vopr Onkol 2010, 56:609-612.
  • [4]Miller AB: Screening for breast cancer in the Eastern Mediterranean Region. East Mediterr Health J 2010, 16:1022-1024.
  • [5]Kwok C, Fethney J, White K: Breast cancer screening practices among Chinese-Australian women. Eur J Oncol Nurs 2012, 16:247-252.
  • [6]Fenech M: Folate, DNA damage and the aging brain. Mech Ageing 2010, 131:236-241.
  • [7]James SJ, Pogribny IP, Pogribna M, Miller BJ, Jernigan S, Melnyk S: Mechanisms of DNA damage, DNA hypomethylation, and tumor progression in the folate/methyl-deficient rat model of hepatocarcinogenesis. J Nutr 2003, 133:3740S-3747S.
  • [8]Naushad SM, Pavani A, Rupasree Y, Sripurna D, Gottumukkala SR, Digumarti RR, Kutala VK: Modulatory effect of plasma folate and polymorphisms in one-carbon metabolism on catecholamine methyltransferase (COMT) H108L associated oxidative DNA damage and breast cancer risk. Indian J Biochem Biophys 2011, 48:283-289.
  • [9]Zwart SR, Jessup JM, Ji J, Smith SM: Saturation diving alters folate status and biomarkers of DNA damage and repair. PLoS One 2012, 7:e31058.
  • [10]Wang TC, Song YS, Wang H, Zhang J, Yu SF, Gu YE, Chen T, Wang Y, Shen HQ, Jia G: Oxidative DNA damage and global DNA hypomethylation are related to folate deficiency in chromate manufacturing workers. J Hazard Mater 2012, 213:440-446.
  • [11]Pufulete M, Emery P, Sanders TA: Folate, DNA methylation and colo-rectal cancer. Proc Nutr Soc 2003, 62:437-445.
  • [12]Radivoyevitch T: Folate system correlations in DNA microarray data. BMC Cancer 2005, 5:95. BioMed Central Full Text
  • [13]Sharp L, Little J: Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiology 2004, 15:423-443.
  • [14]Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN: Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage. Proc Natl Acad Sci U S A 1997, 94:3290-3295.
  • [15]Wang X, Wu X, Liang Z, Huang Y, Fenech M, Xue J: A comparison of folic acid deficiency-induced genomic instability in lymphocytes of breast cancer patients and normal non-cancer controls from a Chinese population in Yunnan. Mutagenesis 2006, 21:41-47.
  • [16]Sellers TA, Kushi LH, Cerhan JR, Vierkant RA, Gapstur SM, Vachon CM, Olson JE, Therneau TM, Folsom AR: Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology 2001, 12:420-428.
  • [17]Stipanuk MH: Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu Rev Nutr 2004, 24:539-577.
  • [18]Phelip JM, Ducros V, Faucheron JL, Flourie B, Roblin X: Association of hyperhomocysteinemia and folate deficiency with colon tumors in patients with inflammatory bowel disease. Inflamm Bowel Dis 2008, 14:242-248.
  • [19]Das PM, Singal R: DNA methylation and cancer. J Clin Oncol 2004, 22:4632-4642.
  • [20]Goelz SE, Vogelstein B, Hamilton SR, Feinberg AP: Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 1985, 228:187-190.
  • [21]Ratter F, Gassner C, Shatrov V, Lehmann V: Modulation of tumor necrosis factor-alpha-mediated cytotoxicity by changes of the cellular methylation state: mechanism and in vivo relevance. Int Immunol 1999, 11:519-527.
  • [22]Bogdanski P, Pupek-Musialik D, Dytfeld J, Lacinski M, Jablecka A, Jakubowski H: Plasma homocysteine is a determinant of tissue necrosis factor-alpha in hypertensive patients. Biomed Pharmacother 2008, 62:360-365.
  • [23]Wu LL, Wu JT: Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker. Clin Chim Acta 2002, 322:21-28.
  • [24]Le Marchand L, Haiman CA, Wilkens LR, Kolonel LN, Henderson BE: MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2004, 13:2071-2077.
  • [25]Ferroni P, Palmirotta R, Martini F, Riondino S, Savonarola A, Spila A, Ciatti F, Sini V, Mariotti S, Del Monte G, Roselli M, Guadagni F: Determinants of homocysteine levels in colorectal and breast cancer patients. Anticancer Res 2009, 29:4131-4138.
  • [26]King WD, Ho V, Dodds L, Perkins SL, Casson RI, Massey TE: Relationships among biomarkers of one-carbon metabolism. Mol Biol Rep 2012, 39:7805-7812.
  • [27]Gao CM, Tang JH, Cao HX, Ding JH, Wu JZ, Wang J, Liu YT, Li SP, Su P, Matsuo K, Takezaki T, Tajima K: MTHFR polymorphisms, dietary folate intake and breast cancer risk in Chinese women. J Hum Genet 2009, 54:414-418.
  • [28]Scazzone C, Acuto S, Guglielmini E, Campisi G, Bono A: Methionine synthase reductase (MTRR) A66G polymorphism is not related to plasma homocysteine concentration and the risk for vascular disease. Exp Mol Pathol 2009, 86:131-133.
  • [29]Reed MC, Nijhout HF, Neuhouser ML, Gregory JF III, Shane B, James SJ, Boynton A, Ulrich CM: A mathematical model gives insights into nutritional and genetic aspects of folate-mediated one-carbon metabolism. J Nutr 2006, 136:2653-2661.
  • [30]Vaughn JD, Bailey LB, Shelnutt KP, Dunwoody KM, Maneval DR, Davis SR, Quinlivan EP, Gregory JF 3rd, Theriaque DW, Kauwell GP: Methionine synthase reductase 66A- > G polymorphism is associated with increased plasma homocysteine concentration when combined with the homozygous methylenetetrahydrofolate reductase 677C- > T variant. J Nutr 2004, 134:2985-2990.
  • [31]de Franchis R, Kraus E, Kozich V, Sebastio G, Kraus JP: Four novel mutations in the cystathionine beta-synthase gene: effect of a second linked mutation on the severity of the homocystinuric phenotype. Hum Mutat 1999, 13:453-457.
  • [32]Kozich V, Sokolová J, Klatovská V, Krijt J, Janosík M, Jelínek K, Kraus JP: Cystathionine beta-synthase mutations: effect of mutation topology on folding and activity. Hum Mutat 2010, 31:809-819.
  • [33]Devor EJ, Dill-Devor RM, Magee HJ, Waziri R: Serine hydroxymethyltransferase pseudogene, SHMT-ps1: a unique genetic marker of the order primates. J Exp Zool 1998, 282:150-156.
  • [34]Inoue-Choi M, Ward MH, Cerhan JR, Weyer PJ, Anderson KE, Robien K: Interaction of nitrate and folate on the risk of breast cancer among postmenopausal women. Nutr Cancer 2012, 64:685-694.
  • [35]Shrubsole MJ, Shu XO, Li HL, Cai H, Yang G, Gao YT, Gao J, Zheng W: Dietary B vitamin and methionine intakes and breast cancer risk among Chinese women. Am J Epidemiol 2011, 173:1171-1182.
  • [36]Zhang CX, Pan MX, Li B, Wang L, Mo XF, Chen YM, Lin FY, Ho SC: Choline and betaine intake is inversely associated with breast cancer risk: a two-stage case–control study in China. Cancer Sci 2013, 104:250-258.
  • [37]Coronado GD, Beasley J, Livaudais J: Alcohol consumption and the risk of breast cancer. Salud Publica Mex 2011, 53:440-447.
  • [38]Fredriksen A, Meyer K, Ueland PM, Vollset SE, Grotmol T, Schneede J: Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Hum Mutat 2007, 28:856-865.
  • [39]Angelaccio S, Florio R, Consalvi V, Festa G, Pascarella S: Serine hydroxymethyltransferase from the cold adapted microorganism psychromonas ingrahamii: a low temperature active enzyme with broad substrate specificity. Int J Mol Sci 2012, 13:1314-1326.
  • [40]Anderson DD, Woeller CF, Chiang EP, Shane B, Stover PJ: Serine hydroxymethyltransferase anchors de novo thymidylate synthesis pathway to nuclear lamina for DNA synthesis. J Biol Chem 2012, 287:7051-7062.
  • [41]Steck SE, Keku T, Butler LM, Galanko J, Massa B, Millikan RC, Sandler RS: Polymorphisms in methionine synthase, methionine synthase reductase and serine hydroxymethyltransferase, folate and alcohol intake, and colon cancer risk. J Nutrigenet Nutrigenomics 2008, 1:196-204.
  • [42]Jokic M, Brcic-Kostic K, Stefulj J, Ivkovic TC, Bozo L, Gamulin M, Kapitanovic S: Association of MTHFR, MTR, MTRR, RFC1, and DHFR gene polymorphisms with susceptibility to sporadic colon cancer. DNA Cell Biol 2011, 30:771-776.
  • [43]Muacević-Katanec D, Kekez T, Fumić K, Barić I, Merkler M, Jakić-Razumović J, Krznarić Z, Zadro R, Katanec D, Reiner Z: Spontaneous perforation of the small intestine, a novel manifestation of classical homocystinuria in an adult with new cystathionine beta-synthetase gene mutations. Coll Antropol 2011, 35:181-185.
  • [44]Wilcken DE, Reddy SG, Gupta VJ: Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria. Metab Clin Exp 1983, 32:363-370.
  • [45]Tsai MY, Wong PW, Garg U, Hanson NQ, Schwichtenberg K: Two novel mutations in the cystathionine beta-synthase gene of homocystinuric patients. Mol Diag 1997, 2:129-133.
  • [46]Kim J, Hong SJ, Park JH, Park SY, Kim SW, Cho EY, Do IG, Joh JW, Kim DS: Expression of cystathionine beta-synthase is downregulated in hepatocellular carcinoma and associated with poor prognosis. Oncol Rep 2009, 21:1449-1454.
  • [47]Prudova A, Bauman Z, Braun A, Vitvitsky V, Lu SC, Banerjee R: S-adenosylmethionine stabilizes cystathionine beta-synthase and modulates redox capacity. Proc Natl Acad Sci U S A 2006, 103:6489-6494.
  • [48]Kraus JP, Le K, Swaroop M, Ohura T, Tahara T, Rosenberg LE, Roper MD, Kozich V: Human cystathionine beta-synthase cDNA: sequence, alternative splicing and expression in cultured cells. Human Mol Genet 1993, 2:1633-1638.
  • [49]Majors AK, Pyeritz RE, Pyeritz : A deficiency of cysteine impairs fibrillin-1 deposition: implications for the pathogenesis of cystathionine beta-synthase deficiency. Mol Genet Metab 2000, 70:252-260.
  • [50]Demple B, Harrison L: Repair of oxidative damage to DNA: enzymology and biology. Annu Rev Biochem 1994, 63:915-948.
  • [51]Laval J: Role of DNA repair enzymes in the cellular resistance to oxidative stress. Pathol Biol (Paris) 1996, 44:14-24.
  • [52]Audebert M, Salles B, Calsou P: Involvement of poly (ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J Biol Chem 2004, 279:55117-55126.
  • [53]Bennecke M, Kriegl L, Bajbouj M, Retzlaff K, Robine S, Jung A, Arkan MC, Kirchner T, Greten FR: Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell 2010, 18:135-146.
  • [54]Ahn JB, Chung WB, Maeda O, Shin SJ, Kim HS, Chung HC, Kim NK, Issa JP: DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer 2011, 117:1847-1854.
  • [55]Ott N, Geddert H, Sarbia M: Polymorphisms in methionine synthase (A2756G) and cystathionine beta-synthase (844ins68) and susceptibility to carcinomas of the upper gastrointestinal tract. J Cancer Res Clin Oncol 2008, 134:405-410.
  • [56]Galbiatti AL, Ruiz MT, Raposo LS, Maniglia JV, Pavarino-Bertelli EC, Goloni-Bertollo EM: The association between CBS 844ins68 polymorphism and head and neck squamous cell carcinoma risk - a case–control analysis. Arch Med Sci 2010, 6:772-779.
  • [57]Yakub M, Moti N, Parveen S, Chaudhry B, Azam I, Iqbal MP: Polymorphisms in MTHFR, MS and CBS genes and homocysteine levels in a Pakistani population. PLoS One 2012, 7:e33222.
  • [58]Booher K, Lin DW, Borrego SL, Kaiser P: Downregulation of Cdc6 and pre-replication complexes in response to methionine stress in breast cancer cells. Cell Cycle 2012, 11:4414-4423.
  • [59]Zhu BT: Medical hypothesis: hyperhomocysteinemia is a risk factor for estrogen-induced hormonal cancer. Int J Oncol 2003, 22:499-508.
  • [60]Zhu BT, Liehr JG: Inhibition of catechol O-methyl- transferase-catalyzed O-methylation of 2- and 4-hydroxy-estradiol by quercetin: possible role in estradiol-induced tumorigenesis. J Biol Chem 1996, 271:1357-1363.
  文献评价指标  
  下载次数:31次 浏览次数:18次